WallStreetZenWallStreetZen

NASDAQ: CADL
Candel Therapeutics Inc Stock Ownership - Who owns Candel Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Candel Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul B. ManningDirector2026-02-23550,458$5.45
$3.00MBuy
William Garrett NicholsChief Medical Officer2025-07-28937$6.98
$6.54kSell
William Garrett NicholsChief Medical Officer2025-07-28937$1.29
$1.21kBuy
William Garrett NicholsChief Medical Officer2025-06-30781$1.29
$1.01kBuy
William Garrett NicholsChief Medical Officer2025-06-30781$5.04
$3.94kSell
Joseph C. PapaDirector2025-06-2564,239$4.67
$300.00kBuy
Charles SchochChief Financial Officer2025-06-255,353$4.67
$25.00kBuy
Paul Peter TakChief Executive Officer2025-06-2542,826$4.67
$200.00kBuy
Francesca BaroneChief Scientific Officer2025-06-254,282$4.67
$20.00kBuy
Seshu TyagarajanChief Technology Officer2025-06-255,353$4.67
$25.00kBuy

1 of 2

CADL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CADL insiders and whales buy or sell their stock.

CADL Shareholders

What type of owners hold Candel Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC11.24%8,234,299$64.15MInstitution
Estuardo Aguilarcordova9.77%7,156,946$55.75MInsider
Paul B. Manning7.85%5,748,279$44.78MInsider
Laura K. Aguilar4.16%3,046,940$23.74MInsider
Blackrock Inc3.91%2,861,689$22.29MInstitution
Acorn Capital Advisors LLC3.52%2,580,517$20.10MInstitution
Vanguard Group Inc3.15%2,305,060$17.96MInstitution
Portolan Capital Management LLC2.31%1,695,367$13.21MInstitution
Geode Capital Management LLC1.33%977,512$7.61MInstitution
State Street Corp1.08%792,218$6.17MInstitution

1 of 3

CADL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CADL32.27%24.06%Net BuyingNet Buying
BBOT63.09%36.91%Net BuyingNet Selling
CRMD53.08%9.65%Net Selling
AGMB0.00%0.09%
DNA11.77%88.23%Net SellingNet Selling
View Top Biotech Stocks

Candel Therapeutics Stock Ownership FAQ

Who owns Candel Therapeutics?

Candel Therapeutics (NASDAQ: CADL) is owned by 32.27% institutional shareholders, 24.06% Candel Therapeutics insiders, and 43.67% retail investors. Estuardo Aguilarcordova is the largest individual Candel Therapeutics shareholder, owning 7.16M shares representing 9.77% of the company. Estuardo Aguilarcordova's Candel Therapeutics shares are currently valued at $59.76M.

If you're new to stock investing, here's how to buy Candel Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.